Detalhe da pesquisa
1.
In vitro characterization of the activity of PF-05095808, a novel biological agent for hepatitis C virus therapy.
Antimicrob Agents Chemother
; 56(3): 1364-75, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22203606
2.
Preclinical studies of PF-04849285, an interferon-α8 fusion protein for the treatment of HCV.
Antivir Ther
; 17(5): 869-81, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22505586
3.
An integrated transcriptomic and meta-analysis of hepatoma cells reveals factors that influence susceptibility to HCV infection.
PLoS One
; 6(10): e25584, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22046242